Pharmaceutical & Biotech Research Laboratory Defense
Isolating clinical trial databases, drug synthesis equipment, and intellectual property repositories from lateral malware movement.
Sector Threat Profile & Operational Vulnerabilities
- •Defending complex distributed networks against targeted ransomware and zero-day exploits in Life Sciences.
- •Maintaining strict compliance mandates (FDA 21 CFR Part 11, GxP) without creating IT administrative bottlenecks.
- •Isolating unmanaged IoT/OT equipment and third-party vendors from mission-critical core databases.
Recommended Network Security Architecture
High-throughput single-pass firewall inspecting all incoming and outgoing connections.
Isolating departmental enclaves, guest subnets, and operational devices into restricted VLANs.
Binding network permissions directly to authenticated user roles and Active Directory groups.
Continuous log streaming to centralized SIEM, generating verifiable FDA 21 CFR Part 11, GxP compliance reports.
Life Sciences - FAQs
Technical and compliance considerations for industry deployment.
4CGuard combines line-rate throughput, deep application inspection, and compliance-specific bypass templates engineered specifically for Life Sciences.
Evaluate 4CGuard on your network topology
Schedule an architectural walkthrough with a network security engineer. Review Layer 7 inspection rules, encrypted payload decapsulation, and Active Directory policy integration.